Core Inflation Hits 32 in March as FirstQuarter GDP Growth Slows to 2 Iran Conflict Drives Oil Prices Higher Bajal Auto Shares Rise Ahead of Dividend Record Date What Investors Should Know HarleyDavidson Navigates Evolving Motorcycle Market Amid Industry Shifts Jim Cramer Weighs In on Analog Devices Market Position in Semiconductor Sector Signos Secures 20M Funding Expands Dexcom Partnership in GLP1 WeightLoss Wave Fed Rate Hike Speculation for 2026 Market Uncertainty Persists ALOY Q1 2024 Earnings EPS Misses Estimates Sharply Stock Rises on No Revenue Disclosure ADAML Q1 2026 Earnings Significant EPS Beat as Preferred Stock Delivers Strong Performance EBAY Q1 2026 Earnings Earnings Beat Estimates as EPS Surpasses Expectations Ituran ITRN Q4 2025 Earnings EPS Slightly Beats Estimates Amid Positive Stock Movement OLLI Q1 2026 Earnings EPS Misses Estimates Amid Challenging Retail Environment Grid Dynamics GDYN Q1 2026 Earnings EPS Beats Estimates Amid Improved Profitability Prestige Consumer Healthcare PBH Holds Near 48 as Modest Decline Tests Support Zone Sentage Holdings Holds Steady at 200 Tight Trading Range Suggests Indecision Tandy Leather Factory TLF Holds Steady at 237 Amid LowVolume Trading Pitney Bowes Faces Resistance as Selling Pressure Intensifies Alterity Therapeutics ATHE Rallies as Trading Volume Increases Testing Resistance Territory Inflation Rate Projected to Hit 6 in Second Quarter Top Economic Forecasters Say GEOS Q1 2026 Earnings Loss Per Share of 086 Reflects Challenging Oilfield Conditions J and Friends Holdings JF Holds Steady at 101 Amid Tight Trading Range ESTC Q1 2026 Earnings EPS Surprise of 1071 Drives Mixed Market Reaction CXM Q1 2026 Earnings EPS Beat of 34 Fails to Lift Stock EPR Properties Q1 2026 Earnings EPS Surges Past Expectations Amid Strong Experiential Demand AIFU Q3 2023 Earnings Strong EPS Amid Market Volatility OCSL Q1 2026 Earnings Slight EPS Beat Amid Stable Portfolio Performance SLGN Q1 2026 Earnings EPS Beats Estimates by 246 Driven by Operational Efficiency Atossa Therapeutics Q1 2026 Earnings Narrowed Loss Beats Estimates as Clinical Pipeline Advances